Genomic health, inc (GHDX)
CashFlow / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Operating activities
Net income

25,677

-3,857

-13,919

-33,308

-24,592

-12,757

8,249

7,846

4,288

-9,411

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

12,669

11,759

8,933

7,069

6,870

6,324

5,471

7,310

7,180

6,591

Employee stock-based compensation

21,090

20,256

18,303

16,005

16,538

17,457

15,104

11,735

10,344

10,155

Write-off of previously capitalized software costs

2,347

76

2,600

635

-

663

-

-

-

-

Impairment of long-lived assets

2,358

22

56

123

375

-

-

-

-

-

Loss on disposal of property and equipment

-27

-35

-33

80

51

-

86

7

45

44

Non-employee stock-based compensation

-

-

-

-

-

-

-

-

15

80

Outside director restricted stock awarded in lieu of fees

200

200

200

200

230

230

172

130

-

-

Gain on sale of equity securities

-

2,807

3,208

-

0

-

-

-

-

-

Discount on convertible promissory note

-

671

-

-

-

-

-

-

-

-

Discount on equity investment

-

-322

-

-

-

-

-

-

-

-

Unrealized net gain on revaluation of equity investments

875

7

-

-

-

-

-

-

-

-

Write-off of convertible promissory note

1,329

-

-

-

-

-

-

-

-

-

Deferred tax benefit from unrealized gain on available-for-sale marketable securities, net

-

820

727

-1,548

-

-

-

-

-

-

Impairment of investments

-

-

-

-

-

643

-

-

-

-

Share of loss of equity method investee

-

-

-

-

-

-

-98

-165

-

-

Changes in assets and liabilities:
Accounts receivable

6,247

-4,018

-1,985

2,248

5,470

7,193

1,176

6,771

3,183

2,316

Prepaid expenses and other assets

2,464

-64

4,556

1,292

-741

1,448

1,599

633

2,365

1,127

Accounts payable

8,374

-2,308

-4,579

949

985

1,238

-2,144

3,057

2,664

-594

Accrued compensation and employee benefits

9,504

-2,947

5,661

4,531

3,824

1,886

1,951

2,222

1,164

2,031

Accrued expenses and other liabilities

2,573

4,164

1,645

-2,963

3,088

1,297

1,608

-1,250

938

1,021

Deferred revenues

-

121

-431

96

-251

212

-1,686

-1,203

583

-1,560

Net cash provided by operating activities

76,562

30,602

13,450

-11,831

2,287

8,552

25,962

22,601

21,583

4,826

Investing activities
Purchases of property and equipment

10,076

13,276

19,786

23,483

10,455

11,008

10,056

6,183

4,442

3,744

Proceeds from sale of property and equipment

55

10

8

70

122

16

206

-

-

-

Purchases of marketable securities

172,563

109,249

69,722

76,743

96,800

107,183

103,570

133,993

84,303

60,318

Maturities of marketable securities

103,979

71,802

66,757

106,439

94,910

116,169

90,160

112,003

87,005

57,225

Proceeds from sales of marketable securities

-

10,155

9,717

-

-

-

-

-

-

-

Other investments

2,500

2,000

6,100

-

2,000

5,000

4,963

2,300

500

-

Net cash used in investing activities

-81,105

-42,558

-19,126

6,283

-14,223

-7,006

-28,223

-30,473

-2,240

-6,837

Financing activities
Principal payments of notes payable

-

-

-

-

-

-

-

-

225

1,814

Proceeds from issuance of common stock under stock plans

26,250

21,776

17,010

12,197

12,030

16,588

18,764

9,558

2,983

1,736

Withholding taxes related to restricted stock units net share settlement

5,498

4,697

3,469

3,842

3,647

2,845

1,272

-

-

-

Repurchase of common stock

-

-

-

-

-

15

30,095

-

-

-

Net cash provided by financing activities

20,752

17,079

13,541

8,355

8,383

13,728

-12,603

9,558

2,758

-78

Net increase in cash, cash equivalents and restricted cash

16,209

5,123

7,865

2,807

-3,553

15,274

-14,864

1,686

22,101

-2,089

Cash paid for income taxes

620

1,093

428

459

432

336

173

243

622

28

Cash paid for interest

-

-

-

-

-

-

-

-

13

120

Non-cash investing and financing activities
Accrued purchases of property and equipment

1,110

717

1,452

3,847

1,809

1,138

1,168

1,010

-

-

Change in fair value of investments

-454

-495

-316

4,269

-

-

-

-

-

-